ClinicalTrials.Veeva

Menu

Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein (REVA)

U

University Hospital of Bordeaux

Status

Completed

Conditions

Arteritis
Diabetes

Treatments

Device: femoropopliteal artery bypass

Study type

Interventional

Funder types

Other

Identifiers

NCT00221715
2000-006
9248-01

Details and patient eligibility

About

When medical treatments fail, critical ischemia of the lower limb often leads to surgery, i.e. above knee femoro popliteal bypass. This bypass can be performed either with DACRON or PTFE prosthesis or with the autologous saphenous vein. Both technics are used but they have not been compared regarding bypass permeability and limb salvage. Thus, this study will compare the permeability rate of above knee femoro popliteal surgery whether performed with autologous vein versus prosthesis

Full description

When medical treatments fail, critical ischemia of the lower limb often leads to surgery, i.e. above knee femoro popliteal bypass. This bypass can be performed with either DACRON or PTFE prosthesis or with the autologous saphenous vein. The principle disadvantages of prosthesis are their prejudged worse permeability and the risk of infection. Too few reliable randomised, multicentric studies in this indication comparing vein bypasses versus prosthesis bypasses have been conducted to firmly confirm the first argument. Thus, the purpose of this multicentric, randomised, national study is to compare, 5 years after surgery, the permeability rate of above knee femoropopliteal bypass with vein versus prosthesis. Primary and secondary permeability, permeability predictive factors, and leg salvage rate will also be assessed. One hundred enrolled patients with II to IV level leg arteritis will randomly be assigned to one of the surgery groups : vein or prosthesis (50 each). The recruiting period will last 3 years and a half, and the follow up 5 years for each patient. The main primary outcome, bypass permeability, will be assessed through Doppler ultrasonography during five years. Secondary endpoints, mortality and morbidity, will be evaluated during the clinical follow up. Permeability predictive factors, primary and secondary permeability, leg salvage will also be recorded. If the permeability rates are equivalent between prosthesis and vein, the use of prosthesis will be preferred as this surgery is easier and faster, and as it is important that the vein remains available for distal revascularisation (where it is more efficient) and for revascularisation of coronary arteries

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • lower limbs arteritis : II to IV arteritis level, above knee femoro popliteal bypass indication
  • signed informed consent

Exclusion criteria

  • no contra indication to the use of prosthesis
  • Available saphenous vein
  • no major trophic trouble

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

1
Experimental group
Description:
bypass by autologous saphenous vein
Treatment:
Device: femoropopliteal artery bypass
Device: femoropopliteal artery bypass
2
Active Comparator group
Description:
bypass by dacron or PTFE Prosthesis
Treatment:
Device: femoropopliteal artery bypass
Device: femoropopliteal artery bypass

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems